Ten Times Earnings

Figures converted from euros at historical FX rates — see data/company.json.fx_rates for the rate table. Ratios, margins, and multiples are unitless and unchanged.

Ten Times Earnings

Wolters Kluwer produced record numbers in 2025 — $7,197m revenue, a 27.5% adjusted operating margin, 18.0% ROIC and $1,584m of adjusted free cash flow — yet the shares trade near $66, roughly ten times earnings and a ~10.5% free-cash-flow yield [1]. A Gordon-growth solve on the ~$14.8bn market capitalisation and $1,584m of adjusted free cash flow implies perpetual FCF growth of roughly minus one to minus two percent at an 8.5–9% cost of equity, against a free-cash-flow record that compounded at 7.6% a year from 2016 to 2025. [2] That is decline, not slower growth, and it is what today's price embeds.

The same buyback engine that produced the record works the other way on the balance sheet: returns run above free cash flow drained total equity to $938m and lifted net debt to $4,728m, or 2.0x EBITDA — the top of the company's 1.5x–2.5x policy band [3] [4] — so a growth disappointment now lands on a thinner cushion.

What that decline read is worth is the point. Discounting $1,584m of free cash flow at the same 8.5–9% cost of equity, if the cash flow merely holds flat in perpetuity the shares are worth about $77 to $81 a share (+16% to +23% from $65.96); at the guided mid-single-digit ~3% growth, about $115 to $125 (+74% to +90%); and even in the price's own implied −2% decline case, $62.63 to $65.60 — roughly 5% below to about level with today. Most of the potential return rides on the market's implied −1% to −2% perpetual decline being wrong, and the decline case itself leaves little further downside from here.

Per-share fair-value cases computed at an 8.5–9% cost of equity on $1,584m of adjusted free cash flow; workings in pro/stakes-checks/va-reverse-dcf-implied-fcf-decline.out.

What the multiple is

The starting point is what the market pays today, and against what. On FY2025 diluted adjusted EPS of $6.22 the shares sit at roughly 10.9x; on the $6.45 consensus estimate for 2026 they are near 10.2x, and on the $7.13 penciled in for 2027, about 9.2x [5]. Adjusted free cash flow of $1,584m against a ~$14.8bn market capitalisation is a 10.5% cash yield. Enterprise value of roughly $19.5bn — equity plus $4,728m of net debt — is about 7.6x EBITDA on market data [6].

Sources: FY2025 adjusted FCF $1,584m and net debt $4,728m per the FY2025 Annual Report [7] [8]; price, EV/EBITDA multiple, and the ~$114 consensus 12-month target are market data, early July 2026.

Two comparisons frame how unusual this is. The first is the company against its own recent past: Wolters Kluwer carried a trailing P/E near 34x at the end of 2024 and averaged roughly 26x over the prior five years, so the ~10.6x it closed 2025 at is a de-rating of about 60% versus its own norm — a re-rating of the multiple far more than a change in the numbers. The second is against the professional-information peers management competes with directly.

Source: forward P/E from aggregated market data, late June–early July 2026; multiples are unitless. Peer identities (RELX, Thomson Reuters, Verisk) per the corpus peer set; each runs a content-plus-analytics subscription model comparable to WKL's.

RELX and Thomson Reuters — the head-to-head rivals in legal and tax whose model most closely mirrors WKL's — trade at roughly 16–19x forward earnings; Verisk, a data-analytics peer, nearer 24x. Wolters Kluwer sits about 40–55% below that band. At ~10x against a cohort at 16–24x, the gap prices faster or more certain erosion of WKL's proprietary expert content than the market expects at its peers — a discount rather than an argument.

The "record" year, cleaned up

Before pricing the future it is worth separating the headline from the run-rate, because a skeptic will. IFRS diluted EPS of $6.63 rose 25% in 2025, but that figure is flattered by items management strips out; adjusted net profit was $1,439m and diluted adjusted EPS $6.22, up 6% as reported and 9% in constant currency after a 3% reduction in the share count to 231.8 million [9]. The underlying earnings power compounded at high single digits, not 25%. The valuation work below uses the adjusted line, which is the cleaner base for what recurs.

What the multiple implies

A cash-generative subscription business worth roughly 10x earnings and yielding 10.5% on free cash flow is priced for very little growth. Treating the market capitalisation as the present value of a growing perpetuity — value equals next year's free cash flow divided by the discount rate less the growth rate — and solving backwards for the growth the price embeds:

Source: derived from FY2025 adjusted FCF $1,584m [10] and ~$14.8bn market capitalisation (market data); free-cash-flow CAGR computed from reported cash flow, 2016 (~$0.8bn) to 2025.

At an 8.5–9% cost of equity — reasonable for a business with 83% recurring revenue [11] — the current price implies free cash flow shrinks by roughly 1–2% a year in perpetuity. That is not slower growth; it is decline. Set against a free-cash-flow record that compounded at 7.6% annually from about $0.8bn in 2016 to $1.6bn in 2025, and 2026 guidance for another year of good organic growth, high-single-digit adjusted-EPS growth and a margin rising toward 28% [12], the price requires WKL's decade-long compounding to reverse into perpetual decline.

The same point read forward: re-rating to RELX's ~16x on an unchanged $6.22 of adjusted earnings would put the shares near $97, about 47% above today; a return to WKL's own five-year-average multiple would imply a figure roughly twice the current price. The consensus 12-month target of about $114 sits inside that range, which is the sell side signalling it views the de-rating as overdone — though targets lag price and have been cut as the shares fell.

The case is most sensitive to the exit multiple

Because near-term earnings are relatively well-anchored — management guides to high-single-digit adjusted-EPS growth [13] and 83% of revenue renews above 90% [14] — the outcome over two to three years turns far more on the multiple the market is willing to pay than on the exact earnings path. The multiple is where the market's content-erosion fear gets priced in or out.

Source: illustrative scenarios by the author. EPS anchored on FY2026–27 consensus ($6.45 / $7.13) flexed for organic-growth outcomes; exit multiples span from below today's 10x to a discount to RELX's ~16x. Current price ~$65.9 (market data).

The span is instructive. Holding earnings at a base-case $7.10, moving the exit multiple from 9x to 14x to 18x runs the price from about $64 to $100 to $128 — a ±50% swing that dwarfs the effect of the earnings flex within each column. In a bear world where AI genuinely commoditises the content, low single-digit growth and a multiple stuck near today's leaves the shares roughly flat to down; in a base case where renewals hold and Expert AI defends the franchise, a partial re-rating to a still-discounted 14x delivers the bulk of the consensus upside without heroic assumptions; only the bull case needs organic growth to inflect up.

What cuts the other way

The discount is not pure fear, and three facts argue the market has some reason. First, the balance sheet is thinner than the compounding headline suggests: total equity fell $878m to $938m in 2025 as buybacks and dividends ran above free cash flow, and net debt rose to $4,728m, or 2.0x EBITDA — the upper half of the company's own 1.5x–2.5x policy band [15] [16]. A business returning more than its free cash flow at 2.0x leverage has less room to absorb a growth disappointment than one at half the gearing. Second, the record IFRS EPS overstates the run-rate, as the adjusted line shows. Third, external analysts have shortened the duration they are willing to underwrite for these franchises — one major research house cut its explicit forecast horizon for Wolters Kluwer from twenty years to fifteen and downgraded its moat assessment, which mechanically lowers a fair-value estimate regardless of any single year's result. A ~10x multiple is cheap against history; it is less obviously cheap against a genuinely shortened franchise life.

What would move the read is specific and dated. The half-year 2026 results on 5 August 2026 carry the first clean organic-growth print since Expert AI began scaling: recurring and cloud organic growth accelerating would evidence a base-or-better case and argue the multiple is wrong; the same lines decelerating, or any softening of the 90%-plus renewal rate, would give the bear-case decline the market is pricing its first real support. Absent that, the position is a wide gap between a ~10x price and a mid-teens-and-above peer group, with the AI-durability question — tested in Expert AI — as the variable that closes it in either direction.